Episona adds D2C model for male fertility test using epigenetics
Seed is a next-generation sequencing test that identifies signs of DNA methylation in sperm as the result of aging, smoking, pollution and other factors.
Epigenetics startup Episona launches male fertility test
The global market for fertility medicine is now $30-40 billion per year, but many continue to view it as a women's health problem. Episona hopes to change that, with its epigenetics-based male fertility test.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.